FinanceAsianet Newsable
Sellas stock rises ahead of Phase 3 AML data
in5points
Sellas Life Sciences stock rose in premarket trading ahead of its Phase 3 AML data readout.
CEO Angelos Stergiou appeared on Fox & Friends to discuss AI and precision medicine.
Stergiou said AI could speed drug development and improve patient selection.
Story angle
Center-right
L
CL
C
CR
R
Mostly straight facts, with a light government- or market-friendly tilt.
About how the story is framed, not whether the facts are true.
Asianet Newsable
Center-right
Mixed factuality
Who owns this?
Asianet News Network
Rajeev Chandrasekhar / Jupiter Capital interests historically